CA2428564A1 - Composition pharmaceutique pour le traitement d'infections contenant une bacterie resistant aux medicaments et desinfectant connexe - Google Patents

Composition pharmaceutique pour le traitement d'infections contenant une bacterie resistant aux medicaments et desinfectant connexe Download PDF

Info

Publication number
CA2428564A1
CA2428564A1 CA002428564A CA2428564A CA2428564A1 CA 2428564 A1 CA2428564 A1 CA 2428564A1 CA 002428564 A CA002428564 A CA 002428564A CA 2428564 A CA2428564 A CA 2428564A CA 2428564 A1 CA2428564 A1 CA 2428564A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
flavonoid
derivatives
composition according
drug resistant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002428564A
Other languages
English (en)
Inventor
Hirofumi Shibata
Takayuki Nakada
Yoichi Sato
Tomihiko Higuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alps Pharmaceutical Ind Co Ltd
Original Assignee
Alps Pharmaceutical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alps Pharmaceutical Ind Co Ltd filed Critical Alps Pharmaceutical Ind Co Ltd
Priority to CA002428564A priority Critical patent/CA2428564A1/fr
Publication of CA2428564A1 publication Critical patent/CA2428564A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002428564A 2003-05-14 2003-05-14 Composition pharmaceutique pour le traitement d'infections contenant une bacterie resistant aux medicaments et desinfectant connexe Abandoned CA2428564A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002428564A CA2428564A1 (fr) 2003-05-14 2003-05-14 Composition pharmaceutique pour le traitement d'infections contenant une bacterie resistant aux medicaments et desinfectant connexe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002428564A CA2428564A1 (fr) 2003-05-14 2003-05-14 Composition pharmaceutique pour le traitement d'infections contenant une bacterie resistant aux medicaments et desinfectant connexe

Publications (1)

Publication Number Publication Date
CA2428564A1 true CA2428564A1 (fr) 2004-11-14

Family

ID=33437968

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002428564A Abandoned CA2428564A1 (fr) 2003-05-14 2003-05-14 Composition pharmaceutique pour le traitement d'infections contenant une bacterie resistant aux medicaments et desinfectant connexe

Country Status (1)

Country Link
CA (1) CA2428564A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113209120A (zh) * 2021-05-27 2021-08-06 河北农业大学 芸香苷及其衍生物在抑制β-内酰胺酶活性中的应用及联合抑菌组合物
CN114699402A (zh) * 2022-04-06 2022-07-05 陕西省微生物研究所 黄酮类化合物用于制备β-内酰胺酶抑制剂的用途
CN116236475A (zh) * 2023-04-24 2023-06-09 聊城大学 桑黄素在制备ndm-1酶抑制剂中的医用用途
CN117959322A (zh) * 2024-02-06 2024-05-03 郑州大学 安石榴苷抗金葡菌的应用
CN118121706A (zh) * 2024-03-11 2024-06-04 吉林大学 杜鹃素联合β-内酰胺类抗生素在制备治疗金黄色葡萄球菌感染所致疾病的药物中的应用

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113209120A (zh) * 2021-05-27 2021-08-06 河北农业大学 芸香苷及其衍生物在抑制β-内酰胺酶活性中的应用及联合抑菌组合物
CN114699402A (zh) * 2022-04-06 2022-07-05 陕西省微生物研究所 黄酮类化合物用于制备β-内酰胺酶抑制剂的用途
CN114699402B (zh) * 2022-04-06 2024-02-06 陕西省微生物研究所 黄酮类化合物用于制备β-内酰胺酶抑制剂的用途
CN116236475A (zh) * 2023-04-24 2023-06-09 聊城大学 桑黄素在制备ndm-1酶抑制剂中的医用用途
CN117959322A (zh) * 2024-02-06 2024-05-03 郑州大学 安石榴苷抗金葡菌的应用
CN118121706A (zh) * 2024-03-11 2024-06-04 吉林大学 杜鹃素联合β-内酰胺类抗生素在制备治疗金黄色葡萄球菌感染所致疾病的药物中的应用

Similar Documents

Publication Publication Date Title
US6294526B1 (en) Use of flavone derivatives for induction of β-lactam-sensitivity of MRSA
JP2003171274A5 (fr)
US20040229825A1 (en) Pharmaceutical composition for treatment of infection with drug resistant bacterium and disinfectant
JP2003171274A (ja) 薬剤耐性菌感染症治療のための医薬組成物および消毒剤
TWI327573B (en) 6-11 bicyclic ketolide derivatives
CA2126513A1 (fr) Agents chondroprotecteurs
ZA200302085B (en) 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents.
IL226538A (en) Compounds for use in the treatment or prevention of bacterial infection that produces carbapenamase
WO2004087728A3 (fr) Derives 9a-azalide 6,11-3c-bicycliques
MX2011002185A (es) Composiciones y metodos de tratamiento que comprenden ceftarolina.
CA2483875A1 (fr) Derives de l'erythromycine 6,11 bicyclique
CA2428564A1 (fr) Composition pharmaceutique pour le traitement d'infections contenant une bacterie resistant aux medicaments et desinfectant connexe
EP2260870A2 (fr) Traitement de maladies infectieuse par des mélanges de dérivés de thioxanthène avec des agents anti-infectieux
ES2316957T3 (es) Composicion medicinal para tratar la infeccion con staphylococcus aureus resistente a farmacos.
JP2952767B2 (ja) フラボン誘導体によるメチシリン耐性黄色ブドウ球菌（Ｍｅｔｈｉｃｉｌｌｉｎ−Ｒｅｓｉｓｔａｎｔ Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ：ＭＲＳＡ）に対するβ−ラクタム剤感受性誘導作用
AU726471B2 (en) Anti-microbial product
WO2006039263A3 (fr) Nouveaux derives 9a-azalidiques bicycliques
CN118416061A (zh) 用于治疗糖尿病足感染的药物
JP5101521B2 (ja) メチシリン耐性黄色ブドウ球菌をオキサシリンに対し感作する組成物および方法
WO2004108746A3 (fr) Derives d'erythromycine bicycliques 11-12
CN106673989A (zh) 一种药物组合物及其制备方法和应用
WO2018039087A1 (fr) Méthodes d'utilisation de médicament antimicrobien et compositions thérapeutiques
JP2015105267A (ja) 併用抗メチシリン耐性黄色ブドウ球菌薬、及びβラクタム系抗生物質の抗菌活性増強剤
WO2004108745A3 (fr) Derives de 11-12-erythromycine bicyclique
WO2005074898A2 (fr) Nouvelle combinaison pour le traitement d'helicobacter pylori

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued